143 related articles for article (PubMed ID: 21854095)
1. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
[No Abstract] [Full Text] [Related]
2. Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.
Gheza F; Cervi E; Pulcini G; Villanacci V; Giulini SM; Schiavo-Lena M; Ferrari AB; Bassotti G
Pancreas; 2011 Jul; 40(5):791-3. PubMed ID: 21673543
[No Abstract] [Full Text] [Related]
3. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
5. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
6. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
Senatore FJ; Ynson ML; Dasanu CA
J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
[TBL] [Abstract][Full Text] [Related]
8. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
[TBL] [Abstract][Full Text] [Related]
9. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.
Kohler I; Jacob D; Budzies J; Lehmann A; Weichert W; Schulz S; Neuhaus P; Röcken C
Am J Clin Pathol; 2011 Feb; 135(2):202-11. PubMed ID: 21228360
[TBL] [Abstract][Full Text] [Related]
13. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
14. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
Aburjania N; Truskinovsky AM; Overman MJ; Lou E
J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
[No Abstract] [Full Text] [Related]
15. Periampullary carcinoma: some important news in histopathology.
Uomo G
JOP; 2014 Mar; 15(2):213-5. PubMed ID: 24618452
[No Abstract] [Full Text] [Related]
16. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
18. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA.
Zhu L; Kim K; Domenico DR; Appert HE; Howard JM
J Surg Oncol; 1996 Feb; 61(2):100-5. PubMed ID: 8606540
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK
Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
